METHODSINMOLECULARBIOLOGYSeriesEditorJohnM.
WalkerSchoolofLifeandMedicalSciencesUniversityofHertfordshireHatfield,Hertfordshire,AL109AB,UKForfurthervolumes:http://www.
springer.
com/series/7651HumanMonoclonalAntibodiesMethodsandProtocolsSecondEditionEditedbyMichaelSteinitzDepartmentofPathology,TheHebrewUniversity,HadassahMedicalSchool,Jerusalem,IsraelEditorMichaelSteinitzDepartmentofPathologyTheHebrewUniversityHadassahMedicalSchoolJerusalem,IsraelISSN1064-3745ISSN1940-6029(electronic)MethodsinMolecularBiologyISBN978-1-4939-8957-7ISBN978-1-4939-8958-4(eBook)https://doi.
org/10.
1007/978-1-4939-8958-4LibraryofCongressControlNumber:2018964050SpringerScience+BusinessMedia,LLC,partofSpringerNature2019Thisworkissubjecttocopyright.
AllrightsarereservedbythePublisher,whetherthewholeorpartofthematerialisconcerned,specicallytherightsoftranslation,reprinting,reuseofillustrations,recitation,broadcasting,reproductiononmicrolmsorinanyotherphysicalway,andtransmissionorinformationstorageandretrieval,electronicadaptation,computersoftware,orbysimilarordissimilarmethodologynowknownorhereafterdeveloped.
Theuseofgeneraldescriptivenames,registerednames,trademarks,servicemarks,etc.
inthispublicationdoesnotimply,evenintheabsenceofaspecicstatement,thatsuchnamesareexemptfromtherelevantprotectivelawsandregulationsandthereforefreeforgeneraluse.
Thepublisher,theauthors,andtheeditorsaresafetoassumethattheadviceandinformationinthisbookarebelievedtobetrueandaccurateatthedateofpublication.
Neitherthepublishernortheauthorsortheeditorsgiveawarranty,expressorimplied,withrespecttothematerialcontainedhereinorforanyerrorsoromissionsthatmayhavebeenmade.
Thepublisherremainsneutralwithregardtojurisdictionalclaimsinpublishedmapsandinstitutionalafliations.
ThisHumanaPressimprintispublishedbytheregisteredcompanySpringerScience+BusinessMedia,LLC,partofSpringerNature.
Theregisteredcompanyaddressis:233SpringStreet,NewYork,NY10013,U.
S.
A.
DedicationThisbookisdedicatedtoGeorgeKlein,1925–2016,agiantcreativeandstimulatingscientistofinniteknowledge,friend,andmentor.
Hislegacyisanever-fadinglighthousetohundredsofformerstudents,co-workers,colleagues,andfriends.
vPrefaceAsecondeditionofSpringerProtocolsbookHumanMonoclonalAntibodiesisanaturaloutcomeoftherapiddevelopmentsintheareaandtheremarkableinterestattractedbyour2014rsteditionofthebook.
Itisamazingwhatarapidanddramaticdevelopmenthasoccurredintheeldofhumanmonoclonalantibodiessincethersttimethesewereproducedinthelaboratory.
ItwasthepioneeringstudyinitiatedbyProfessorGeorgeKleininStockholmin1977[1]thatshowedthefeasibilityofmakingsuchantibodiesfromimmortalizedperipheralbloodantigen-committedhumanBlymphocytes.
Theextensivebasicimmuneresearchwhichhastakenplaceduringthelastyearsrapidlyconvergedintotheclinic.
TheFastanddramaticdevelopmentofnovelimmunetreatmentsintheclinicusinghumanmonoclonalantibodiesurgedtheimprovementsoftraditionalandalsocompletelynewtechniquesinvolvedintheproductionoftheantibodies.
Theintroduc-tionofmonoclonalantibodiesdirectedagainstlymphocytecell-surfacecostimulatory/immunecheckpointreceptorsthatmediatetheimmuneresponsehasbeenrevolutionary.
Theseantibodiesenableovercomeimmuneunresponsiveness(i.
e.
,tolerance)ofTcells.
Antibodiesagainstcostimulatorylymphocytereceptorswhichnowareusedintheclinicprovedverybenecialfortumorpatientsatleastinrelationtosometypesofcancer.
Continuousprogressinmoleculartechniquesenablesgenuinemanagementofantibodymolecules.
SuchreagentsintroducedintocytotoxicTcellspromisenewhorizonsforthetreatmentofcancerpatients.
ThepresentSpringerProtocolsbookreectssomeoftherecentdevelopmentsinthearea.
Itincludesseveralcompletelynewchaptersrelatedtotopicsthatwerenotdiscussedintherstedition.
Inaddition,somechaptersfromthersteditionareupdatedwithnecessaryrevisions.
Similartotherstedition,besidesthedetailedspecictechnicalprotocols,thereareafewreviewmanuscriptstoo.
Jerusalem,IsraelMichaelSteinitzReference1.
SteinitzM,KleinG,KoskimiesS,Ma¨kela¨O(1977)EBVvirusinducedBlymphocytecelllinesproducingspecicantibody.
Nature269:420–422viiContentsPrefaceviiContributors.
xi1HumanMonoclonalAntibodies:TheBenetsofHumanization1HermanWaldmann2CancerImmunotherapy:TheDawnofAntibodyCocktails.
11IlariaMarrocco,DonatellaRomaniello,andYosefYarden3IgMNaturalAutoantibodiesinPhysiologyandtheTreatmentofDisease.
53MahboobehFereidan-Esfahani,TarekNayfeh,ArthurWarrington,CharlesL.
Howe,andMosesRodriguez4MonoclonalAntibodiesfortheTreatmentofMelanoma:PresentandFutureStrategies83MadhuriBhandaruandAnandRotte5AnEfcientMethodtoGenerateMonoclonalAntibodiesfromHumanBCells109JennaJ.
Guthmiller,HaleyL.
Dugan,KarlynnE.
Neu,LindaYu-LingLan,andPatrickC.
Wilson6IsolationofAntigen-Specic,Antibody-SecretingCellsUsingaChip-BasedImmunospotArray147HiroyukiKishi,TatsuhikoOzawa,HiroshiHamana,EijiKobayashi,andAtsushiMuraguchi7PuricationofHumanMonoclonalAntibodiesandTheirFragments.
163NicoleUlmer,SebastianVogg,ThomasMu¨ller-Spa¨th,andMassimoMorbidelli8One-TubeMulticolorFlowCytometryAssay(OTMA)forComprehensiveImmunophenotypingofPeripheralBlood189Anna-JasminaDonaubauer,PaulF.
Ru¨hle,InaBecker,RainerFietkau,UdoS.
Gaipl,andBenjaminFrey9HumanizationandSimultaneousOptimizationofMonoclonalAntibody213TaichiKuramochi,TomoyukiIgawa,HiroyukiTsunoda,andKunihiroHattori10AntibodyFragmentsHumanization:BeginningwiththeEndinMind231NicolasAubreyandPhilippeBilliald11Antigen-SpecicHumanMonoclonalAntibodiesfromTransgenicMice253SusanaMagadanMompoandAfricaGonzalez-Fernandez12ReningtheQualityofMonoclonalAntibodies:GraftingUniquePeptide-BindingSiteintheFabFramework293JeremyD.
KingandJohnC.
Williams13BasicProceduresforDetectionandCytotoxicityofChimericAntigenReceptors299KeichiroMihara,TetsumiYoshida,andJoyeetaBhattacharyyaix14RapidChimerizationofAntibodies307KojiHashimoto,KoheiKurosawa,HidetakaSeo,andKunihiroOhta15PhageDisplayTechnologyforHumanMonoclonalAntibodies.
319MarcoDalFerro,SerenaRizzo,EmanuelaRizzo,FrancescaMarano,ImmacolataLuisi,OlgaTarasiuk,andDanieleSblattero16RecombinantAntibodySelectionsbyCombiningPhageandYeastDisplay339FortunatoFerrara,MariaFeliciaSoluri,andDanieleSblattero17EpitopeMappingviaPhageDisplayfromSingle-GeneLibraries353ViolaFu¨hner,PhilipAlexanderHeine,KilianJohannesCarlZilkens,DorisMeier,KristianDanielRalphRoth,GustavoMarcalSchmidtGarciaMoreira,MichaelHust,andGiulioRusso18AHigh-ThroughputMagneticNanoparticle-BasedSemi-AutomatedAntibodyPhageDisplayBiopanning377AngelaChiewWenCh'ng,AzimahAhmad,ZoltanKonthur,andTheamSoonLim19ABindingPotencyAssayforPritumumabandEcto-DomainVimentin.
401IvanBabic,SantoshKesari,andMarkC.
Glassy20AMethodtoDetecttheBindingofHyper-GlycosylatedFragmentCrystallizable(Fc)RegionofHumanIgG1toGlycanReceptors417PatriciaBlundellandRichardPleass21ACell-BasedReporterAssayMeasuringtheActivationofFcGammaReceptorsInducedbyTherapeuticMonoclonalAntibodies423MichihikoAoyama,MinoruTada,andAkikoIshii-Watabe22"BIClonals":ProductionofBispecicAntibodiesinIgGFormatinTransientlyTransfectedMammalianCells.
431DanaLitvak-Greenfeld,LilachVaks,StavDror,LimorNahary,andItaiBenhar23ProductionofStabilizedAntibodyFragmentsintheE.
coliBacterialCytoplasmandinTransientlyTransfectedMammalianCells455RacheliBirnboim-Perach,YehuditGrinberg,LilachVaks,LimorNahary,andItaiBenharIndex481xContentsContributorsAZIMAHAHMADInstituteforResearchinMolecularMedicine,UniversitiSainsMalaysia,Penang,MalaysiaMICHIHIKOAOYAMADivisionofBiologicalChemistryandBiologicals,NationalInstituteofHealthSciences,Kawasaki,Kanagawa,JapanNICOLASAUBREYUMRUniversite-INRAISP1282,BioMAP,UniversitedeTours,Tours,FranceIVANBABICDepartmentofTranslationalNeurosciencesandNeurotherapeutics,JohnWayneCancerInstitute,SantaMonica,CA,USAINABECKERDepartmentofRadiationOncology,Universita¨tsklinikumErlangen,Friedrich-Alexander-Universita¨tErlangen-Nu¨rnberg,Erlangen,GermanyITAIBENHARSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelMADHURIBHANDARUDepartmentofDermatologyandSkinScience,UniversityofBritishColumbia,Vancouver,BC,CanadaJOYEETABHATTACHARYYADepartmentofCardiacResearch,CumballaHillHospitalandHeartInstitute,Mumbai,IndiaPHILIPPEBILLIALDSchoolofPharmacy,Paris-SudUniversity,Chatenay-Malabry,FranceRACHELIBIRNBOIM-PERACHSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelPATRICIABLUNDELLLiverpoolSchoolofTropicalMedicine,Liverpool,UKANGELACHIEWWENCH'NGInstituteforResearchinMolecularMedicine,UniversitiSainsMalaysia,Penang,MalaysiaMARCODALFERRODepartmentofLifeSciences,UniversityofTrieste,Trieste,ItalyANNA-JASMINADONAUBAUERDepartmentofRadiationOncology,Universita¨tsklinikumErlangen,Friedrich-Alexander-Universita¨tErlangen-Nu¨rnberg,Erlangen,GermanySTAVDRORSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelHALEYL.
DUGANCommitteeonImmunology,UniversityofChicago,Chicago,IL,USAMAHBOOBEHFEREIDAN-ESFAHANIDepartmentofNeurology,MayoClinic,Rochester,MN,USAFORTUNATOFERRARASpecicaInc.
,SantaFe,NM,USARAINERFIETKAUDepartmentofRadiationOncology,Universita¨tsklinikumErlangen,Friedrich-Alexander-Universita¨tErlangen-Nu¨rnberg,Erlangen,GermanyBENJAMINFREYDepartmentofRadiationOncology,Universita¨tsklinikumErlangen,Friedrich-Alexander-Universita¨tErlangen-Nu¨rnberg,Erlangen,GermanyVIOLAFU¨HNERAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyUDOS.
GAIPLDepartmentofRadiationOncology,Universita¨tsklinikumErlangen,Friedrich-Alexander-Universita¨tErlangen-Nu¨rnberg,Erlangen,GermanyMARKC.
GLASSYDepartmentofTranslationalNeurosciencesandNeurotherapeutics,JohnWayneCancerInstitute,SantaMonica,CA,USA;TranslationalNeuro-OncologyLaboratory,UCSDMooresCancerCenter,LaJolla,CA,USA;NascentBiotech,Inc.
,SanDiego,CA,USAxiAFRICAGONZALEZ-FERNANDEZImmunology,CentrodeInvestigacionesBiomedicas(CINBIO),CentrodeInvestigacionSingulardeGalicia,InstitutodeInvestigacionSanitariaGaliciaSur,UniversidaddeVigo,Vigo,SpainYEHUDITGRINBERGSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelJENNAJ.
GUTHMILLERDepartmentofMedicine,SectionofRheumatology,TheKnappCenterforLupusandImmunology,UniversityofChicago,Chicago,IL,USAHIROSHIHAMANADepartmentofImmunology,GraduateSchoolofMedicineandPharmaceuticalSciences,UniversityofToyama,Toyama,JapanKOJIHASHIMOTODepartmentofLifeSciences,GraduateSchoolofArtsandSciences,TheUniversityofTokyo,Tokyo,JapanKUNIHIROHATTORIResearchDivision,ChugaiPharmaceutical,Kamakura,Kanagawa,JapanPHILIPALEXANDERHEINEAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyCHARLESL.
HOWEDepartmentofNeurology,MayoClinic,Rochester,MN,USAMICHAELHUSTAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyTOMOYUKIIGAWAChugaiPharmabodyResearchPte.
Ltd.
,Singapore,SingaporeAKIKOISHII-WATABEDivisionofBiologicalChemistryandBiologicals,NationalInstituteofHealthSciences,Kawasaki,Kanagawa,JapanSANTOSHKESARIDepartmentofTranslationalNeurosciencesandNeurotherapeutics,JohnWayneCancerInstitute,SantaMonica,CA,USAJEREMYD.
KINGDepartmentofMolecularMedicine,BeckmanResearchInstituteatCityofHope,Duarte,CA,USAHIROYUKIKISHIDepartmentofImmunology,GraduateSchoolofMedicineandPharmaceuticalSciences,UniversityofToyama,Toyama,JapanEIJIKOBAYASHIDepartmentofImmunology,GraduateSchoolofMedicineandPharmaceuticalSciences,UniversityofToyama,Toyama,JapanZOLTANKONTHURDepartmentofBiomolecularSystems,MaxPlanckInstituteofColloidsandInterfaces,Potsdam,GermanyTAICHIKURAMOCHIChugaiPharmabodyResearchPte.
Ltd.
,Singapore,SingaporeKOHEIKUROSAWADepartmentofLifeSciences,GraduateSchoolofArtsandSciences,TheUniversityofTokyo,Tokyo,JapanLINDAYU-LINGLANCommitteeonImmunology,UniversityofChicago,Chicago,IL,USATHEAMSOONLIMInstituteforResearchinMolecularMedicine,UniversitiSainsMalaysia,Penang,Malaysia;AnalyticalBiochemistryResearchCentre,UniversitiSainsMalaysia,Penang,MalaysiaDANALITVAK-GREENFELDSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelIMMACOLATALUISIDepartmentofLifeSciences,UniversityofTrieste,Trieste,ItalySUSANAMAGADANMOMPOImmunology,CentrodeInvestigacionesBiomedicas(CINBIO),CentrodeInvestigacionSingulardeGalicia,InstitutodeInvestigacionSanitariaGaliciaSur,UniversidaddeVigo,Vigo,SpainFRANCESCAMARANODepartmentofLifeSciences,UniversityofTrieste,Trieste,ItalyILARIAMARROCCODepartmentofBiologicalRegulation,WeizmannInstituteofScience,Rehovot,IsraelxiiContributorsDORISMEIERAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyKEICHIROMIHARADepartmentofHematologyandOncology,ResearchInstituteforRadiationBiologyandMedicine,HiroshimaUniversity,Hiroshima,JapanMASSIMOMORBIDELLIETHZurich,InstituteforChemicalandBioengineering,Zurich,SwitzerlandGUSTAVOMARCALSCHMIDTGARCIAMOREIRAAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyTHOMASMU¨LLER-SPA¨THETHZurich,InstituteforChemicalandBioengineering,Zurich,SwitzerlandATSUSHIMURAGUCHIDepartmentofImmunology,GraduateSchoolofMedicineandPharmaceuticalSciences,UniversityofToyama,Toyama,JapanLIMORNAHARYSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelTAREKNAYFEHDepartmentofNeurology,MayoClinic,Rochester,MN,USAKARLYNNE.
NEUDepartmentofMedicine,SectionofRheumatology,TheKnappCenterforLupusandImmunology,UniversityofChicago,Chicago,IL,USA;CommitteeonImmunology,UniversityofChicago,Chicago,IL,USAKUNIHIROOHTADepartmentofLifeSciences,GraduateSchoolofArtsandSciences,TheUniversityofTokyo,Tokyo,JapanTATSUHIKOOZAWADepartmentofImmunology,GraduateSchoolofMedicineandPharmaceuticalSciences,UniversityofToyama,Toyama,JapanRICHARDPLEASSLiverpoolSchoolofTropicalMedicine,Liverpool,UKSERENARIZZODepartmentofLifeSciences,UniversityofTrieste,Trieste,ItalyEMANUELARIZZODepartmentofLifeSciences,UniversityofTrieste,Trieste,ItalyMOSESRODRIGUEZDepartmentofNeurology,MayoClinic,Rochester,MN,USADONATELLAROMANIELLODepartmentofBiologicalRegulation,WeizmannInstituteofScience,Rehovot,IsraelKRISTIANDANIELRALPHROTHAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyANANDROTTEDepartmentofClinicalPharmacology,GenentechResearchandEarlyDevelopment,SouthSanFrancisco,CA,USA;DepartmentofClinicalandRegulatoryAffairs,NevroCorp.
,RedwoodCity,CA,USAPAULF.
RU¨HLEDepartmentofRadiationOncology,Universita¨tsklinikumErlangen,Friedrich-Alexander-Universita¨tErlangen-Nu¨rnberg,Erlangen,GermanyGIULIORUSSOAbteilungBiotechnologie,Institutfu¨rBiochemie,BiotechnologieundBioinformatik,TechnischeUniversita¨tBraunschweig,Braunschweig,GermanyDANIELESBLATTERODepartmentofLifeSciences,UniversityofTrieste,Trieste,ItalyHIDETAKASEODepartmentofLifeSciences,GraduateSchoolofArtsandSciences,TheUniversityofTokyo,Tokyo,JapanMARIAFELICIASOLURIDepartmentofHealthSciencesandIRCAD,UniversityofPiemonteOrientale(UPO),Novara,ItalyMINORUTADADivisionofBiologicalChemistryandBiologicals,NationalInstituteofHealthSciences,Kawasaki,Kanagawa,JapanOLGATARASIUKDepartmentofHealthSciencesandIRCAD,UniversityofEasternPiedmont,Novara,ItalyContributorsxiiiHIROYUKITSUNODAResearchDivision,ChugaiPharmaceutical,Kamakura,Kanagawa,JapanNICOLEULMERETHZurich,InstituteforChemicalandBioengineering,Zurich,SwitzerlandLILACHVAKSSchoolofMolecularCellBiologyandBiotechnology,TheGeorgeS.
WiseFacultyofLifeSciences,Tel-AvivUniversity,RamatAviv,IsraelSEBASTIANVOGGETHZurich,InstituteforChemicalandBioengineering,Zurich,SwitzerlandHERMANWALDMANNSirWilliamDunnSchoolofPathology,OxfordUniversity,Oxford,UKARTHURWARRINGTONDepartmentofNeurology,MayoClinic,Rochester,MN,USAJOHNC.
WILLIAMSDepartmentofMolecularMedicine,BeckmanResearchInstituteatCityofHope,Duarte,CA,USAPATRICKC.
WILSONDepartmentofMedicine,SectionofRheumatology,TheKnappCenterforLupusandImmunology,UniversityofChicago,Chicago,IL,USA;CommitteeonImmunology,UniversityofChicago,Chicago,IL,USAYOSEFYARDENDepartmentofBiologicalRegulation,WeizmannInstituteofScience,Rehovot,IsraelTETSUMIYOSHIDADepartmentofHematologyandOncology,ResearchInstituteforRadiationBiologyandMedicine,HiroshimaUniversity,Hiroshima,JapanKILIANJOHANNESCARLZILKENSYUMABGmbH,Braunschweig,GermanyxivContributors
2022年春节假期陆续结束,根据惯例在春节之后各大云服务商会继续开始一年的促销活动。今年二月中旬会开启新春采购季的活动,我们已经看到腾讯云商家在春节期间已经有预告活动。当时已经看到有抢先优惠促销活动,目前我们企业和个人可以领取腾讯云代金券满减活动,以及企业用户可以领取域名优惠低至.COM域名1元。 直达链接 - 腾讯云新春采购活动抢先看活动时间:2022年1月20日至2022年2月15日我们可以在...
快云科技怎么样?快云科技是一家成立于2020年的新起国内主机商,资质齐全 持有IDC ICP ISP等正规商家。云服务器网(yuntue.com)小编之前已经介绍过很多快云科技的香港及美国云服务器了,这次再介绍一下新的优惠方案。目前,香港云沙田CN2云服务器低至29元/月起;美国超防弹性云/洛杉矶CUVIP低至33.6元/月起。快云科技的云主机架构采用KVM虚拟化技术,全盘SSD硬盘,RAID10...
imidc怎么样?imidc彩虹网路,rainbow cloud知名服务器提供商。自营多地区数据中心,是 Apnic RIPE Afrinic Arin 认证服务商。拥有丰富的网路资源。 在2021年 6.18 开启了输血大促销,促销区域包括 香港 台湾 日本 莫斯科 等地促销机型为 E3係,参与促销地区有 香港 日本 台湾 莫斯科 等地, 限量50台,售罄为止,先到先得。所有服务器配置 CPU ...
www.idanmu.com为你推荐
newworldNew World Group是什么组织商标注册流程及费用申请商标的流程和花费及时间是什么广东GDP破10万亿广东省2019年各市gdp是多少?刘祚天你们知道21世纪的DJ分为几种类型吗?(答对者重赏)www.kanav001.com长虹V001手机小游戏下载的网址是什么抓站工具抓鸡要什么工具?www.123qqxx.com我的首页http://www.hao123.com被改成了http://www.669dh.cn/?yhcwww.qqq147.comhttp://www.qqhenhenlu.com谁有大片地址呀 麻烦告诉我 谢谢啦 O会给你打满分的dpscycle国服魔兽WLK,有什么适合死亡骑士的插件?
windows虚拟主机 西安服务器 联通c套餐 青果网 eq2 丹弗 建立邮箱 服务器维护方案 工作站服务器 tna官网 vip购优惠 中国电信宽带测速器 cloudlink google台湾 双线asp空间 智能dns解析 smtp服务器地址 中国电信测速网站 1美元 netvigator 更多